No Detail Found!

Expression Analysis of the Peripheral Blood Mononuclear Cells miR-21 and miR-155 in Systemic Lupus Erythematosus Patients and Healthy Controls

Author(s)
Seyedeh Somayeh Hosseini Alarzi Laboratory Sciences Research Center, Golestan University of Medical Sciences,Gorgan,Iran
Mehrdad Aghaie Golestan Rheumatology Research Center (JBCRC), Golestan University of Medical Sciences,Gorgan,Iran
Nader Mansour Samaei Stem Cell Research Center, Golestan University of Medical Sciences,Gorgan,Iran
Mohammad Reza Rabiei Department of Statistics, Faculty of Mathematical Sciences, Shahrood University of Technology,Shahrood,Iran
Arman Soleimanifar Metabolic Disorders Research Center, Golestan University of Medical Sciences,Gorgan,Iran
Behnaz Bazrafshan Stem Cell Research Center, Golestan University of Medical Sciences,Gorgan,Iran
Mohsen Saeidi Stem Cell Research Center, Golestan University of Medical Sciences,Gorgan,Iran
Abstract
Background: Systemic lupus erythematosus (SLE) is an autoimmune disease with variable clinical manifestations mostly affecting the skin, joints, hematopoietic system, kidney, and the central nervous system. The micro-RNAs (miR) are small, non-coding, endogenous RNAs, with key roles in many biological processes. The aim of this study was to investigate the cellular expression of miR-21 and miR-155 in SLE patients and healthy controls. Methods: SLE patients (n=35) and matched healthy controls (n=35) were enrolled in this study. SLE activity was assessed with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score. The peripheral blood mononuclear cells (PBMC) were isolated and the RNA was extracted following cDNA synthesis. The expression of miR-21 and miR-155 was evaluated by the real-time PCR technique. Results: The results showed that the expression level of miR-21 was significantly reduced in patients (0.64 times and pvalue=0.02) and significantly correlated with disease duration. However, no significant differences were observed between the patients and control subjects for miR-155 (pvalue =0.42). Moreover, the expression of miR-21 was indirectly correlated with the disease duration (R=-0.24, p-value = 0.05), but miR-155 did not reveal any significant association with clinicopathological suggests a significant down-regulation of miR-21 in PBMC of SLE patient, mostly in individuals with a longer disease history.
Publication Details
Page(s) 22-28
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 9, Issue: 1, Year: 2020

Request the full text from PASTIC

Keywords
SLEDAI, miRNA-21, PBMC, miRNA-155, Systemic lupus erythematosus
References
Zhao S,Long H,Lu Q. .2010 .Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin Rev Allergy Immunol, 39(1) : 3-9.
Fan W,Liang D,Tang Y .2012 .Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum, 64(11) : 3715-3725.
Wahid F,Shehzad A,Khan T,Kim YY .2010 .MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta, 1803 : 1231-1243.
Vinuesa CG,Rigby RJ,Yu D .2009 .Logic and extent of miRNA-mediated control of autoimmune gene expression. Int Rev Immunol, 28(3-4) : 112-138.
Kumarswamy R,Volkmann I,Thum T. Regulation . .and function of miRNA-21 in health and disease. RNA Biol., : .
Buscaglia LE,Li Y .2011 .Apoptosis and the target genes of microRNA-21. , 30(6) : 371-380.
Garchow B,Kiriakidou M. .2016 .MicroRNA-21 deficiency protects from lupus-like autoimmunity in the chronic graft-versus-host disease model of systemic lupus erythematosus. Clin Immunol, 162 : 100-106.
.2014 .Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun, 15(2) : 115-125.
Löffler D,Brocke-Heidrich K,Pfeifer G .2007 .Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood, 110(4) : 1330-1333.
Urbich C,Kuehbacher A,Dimmeler S. .2008 .Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res, 79(4) : 581-588.
Ruan Q,Wang T,Kameswaran V .2011 .The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A, 108(29) : 12030-12035.
Seddiki N,Brezar V,Ruffin N,Lévy Y,Swaminathan S Y .2014 .Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology, 142(1) : 32-38.
Liu G,Abraham E. .2013 .MicroRNAs in immune response and macrophage polarization. Arterioscler Thromb Vasc Biol, 33(2) : 170-177.
Paraboschi EM,Soldà G,Gemmati D .2011 .Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. Int J Mol Sci, 12(12) : 8695-8712.
Chen XM,Huang QC,Yang SL .2015 .Role of Micro RNAs in the Pathogenesis of Rheumatoid Arthritis: Novel Perspectives Based on Review of the Literature. Medicine (Baltimore), 94(31) : e1326.
Mak A,Tay SH .2014 .Environmental factors, toxicants and systemic lupus erythematosus. Int J Mol Sci, 15(9) : 16043-16056.
Li HW,Xie Y,Li F,Sun GC,Chen Z,Zeng HS .2016 .Effect of miR-19a and miR-21 on the JAK/STAT signaling pathway in the peripheral blood mononuclear cells of patients with systemic juvenile idiopathic arthritis. Exp Ther Med, 11(6) : 2531-2536.
Wang S,Wan X,Ruan Q.,The Q. .2016 .. in Autoimmune Diseases. Int J Mol Sci, 17(6) : 864.
Quinn SR,O'Neill LA SR .2011 .A trio of microRNAs that control Toll-like receptor signalling. Int Immunol, 23(7) : 421-425.
Rasmussen TK,Andersen T,Bak RO .2015 .Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus. Arthritis Res Ther, 17(1) : 154.
Dong L,Wang X,Tan J .2014 .Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J Cell Mol Med, 18(11) : 2213-2224.
Stagakis E,Bertsias G,Verginis P .2011 .Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. , 70(8) : 1496-1506.
Wang H,Peng W,Ouyang X,Li W,Dai Y .2012 .Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res, 160(3) : 198-206.
Fang Z.M.,Wang M.,Cai J.P.,Wang P.C.,Hu P.,L.H. P. .2014 .Clinical relevance of plasma miR-21 in new onset systemic lupus erythematosus patients. J. Clin. Lab. Anal, 28 : 446-451.
Dai R,Zhang Y,Khan D .2010 .Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One, 5(12) : e14302.
Wang G,Tam LS,Li EK,Kwan BC,Chow KM,Luk CC .2010 .Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol, 37 : 2516-22.
Wang G,Tam LS,Kwan BC,Li EK,Chow KM,Luk CC .2012 .Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol, 31 : 435-40.
Xin Q.,Li J.,Dang J.,Bian X.,Shan S.,Yuan J.,Qian Y.,Liu G.,Yuan Q. .2015 .-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr/lpr Mice. J. Immunol, 194 : 5437-5445.
Rasmussen TK,Andersen T,Bak RO .2015 .Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus. Arthritis Research & Therapy, 17 : 154.
0

Citations

0

Downloads

11

Views